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a cause of endocarditis as well as the 
occurrence of mycoplasma bacteremia 
in the absence of underlying infection 
of the endocardium.
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Human Rhinovirus 
Group C Infection 
in Children with 
Lower Respiratory 
Tract Infection
To the Editor: Human rhinovi-
ruses (HRVs), members of the family 
Picornaviridae, were ﬁ  rst isolated in 
1956 (1); to date, >100 serotypes have 
been identiﬁ  ed on the basis of nucle-
otide sequence homologies. HRVs 
were previously divided into 2 genetic 
groups, HRV-A (n = 75) and HRV-B 
(n = 25). Recently, a putative new and 
distinct rhinovirus group, HRV-C, has 
been reportedly found in some patients 
with respiratory tract infections (RTIs) 
(2–8). To extend these initial ﬁ  ndings 
and assess the pathogenicity of HRV-C, 
we investigated its prevalence as well 
as its clinical and molecular features 
in children with lower acute RTIs in 
Beijing, People’s Republic of China.
From July through December 
2007, nasopharyngeal aspirates were 
collected from 258 children (167 boys 
and 91 girls) who had lower acute 
RTIs at the time of their admission 
to Beijing Children’s Hospital. The 
children were 1 month to 15 years 
of age (mean age 37 months, median 
age 10 months). Nucleic acids were 
extracted from clinical samples by us-
ing the NucliSens easyMAG platform 
(bioMérieux SA, Marcy L’Etoile, 
France). Each specimen was tested for 
the presence of common respiratory 
viruses: human parainﬂ  uenza viruses 
1–4, inﬂ   uenza viruses, respiratory 
syncytial virus, enteroviruses, human 
coronaviruses (229E, NL63, HKU1, 
and OC43), metapneumovirus, adeno-
viruses, and bocaviruses. To study the 
prevalence of HRV-C, we designed 
a speciﬁ   c reverse transcription–PCR 
(RT-PCR) that generated a 330-bp 
PCR product encompassing a portion 
of the 5′-untranslated region, the full 
virus capsid protein (VP) 4 gene, and a 
portion of the VP2 gene of the HRV-C 
genome. (All primer sequences and 
protocols of these assays are available 
from J.W. upon request.)
This RT-PCR detected HRV-C 
in 14 patients (12 boys and 2 girls, 1 
month to 13 years of age [mean age 
19 months, median age 6 months]). In 
6 of the 14 patients, HRV-C was the 
only virus detected, which suggests 
a direct correlation between HRV-C 
infection and lower acute RTIs. In the 
remaining 8 patients, other respiratory 
viruses were also detected. Respirato-
ry syncytial virus, the most important 
cause of lower acute RTIs in children, 
was codetected in 7 of the HRV-C–
positive patients, and human parain-
ﬂ  uenza virus 3 was codetected in the 
other patient. Human coronavirus 
NL63 was codetected with respiratory 
syncytial virus in 1 HRV-C–positive 
patient. 
HRV-C infection may be season-
al. This virus was detected during only 
3 of the 6 months in which specimens 
were collected. Speciﬁ  cally,  HRV-C 
was detected in samples collected in 
October (7/50), November (5/96), and 
December (2/8) but not in those col-
lected in July (0/37), August (0/42), 
or September (0/25). In contrast, 
HRV-A and HRV-B were detected in 
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each month (data not shown). Indeed, 
from July through December, HRV-A 
and HRV-B viruses were detected in 
34 and 12 patients, respectively. No-
tably, in October 2007, HRV-C was 
detected in 7 patients, while HRV-A 
and HRV–B were detected in 5 and 2 
patients, respectively, which suggests 
that the cluster of cases of HRV infec-
tions during this month was caused 
mainly by HRV-C.
The 14 HRV-C–positive patients 
had a variety of other diseases includ-
ing pneumonia (6/14), bronchopneu-
monia (4/14), and peribronchiolitis 
(3/14). The most common clinical 
ﬁ   ndings were cough (14/14), fever 
(9/14), and abnormal breath sounds 
on auscultation (11/14). Radiographic 
results were available for 10 of the 14 
HRV-C–positive patients, all of whom 
had increased lung markings or patchy 
shadows. Although 3 of the 14 patients 
required admission to the pediatric in-
tensive care ward, their clinical out-
comes were favorable.
Phylogenetic analysis showed 
that the 14 sequences obtained during 
this study (GenBank accession nos. 
EU687515–EU687528) together with 
previously reported sequences formed 
a novel group of rhinoviruses (Figure). 
Six sequences (BCH221, BCH264, 
BCH200, BCH341, BCH217, and 
BCH250) displayed high similarity 
to HRV C025 (EF582386) from Hong 
Kong (4); 2 sequences (BCH249 and 
BCH343) displayed high similarity to 
NAT083 (EF077264) from the United 
States (3) and Picornaviridae strain 
06-646 (EU081811) from Germany 
(5). BCH242 was similar to Picorna-
viridae strain tu403 (EU081795) from 
Germany (5). The other 5 strains were 
homologous to strains from Australia 
(EU155152–EU155154, EU155158) 
(2,7). These ﬁ  ndings suggest that, as in 
other countries (5), the HRV-C strains 
circulating in China are diverse. Al-
though HRV-C strains belonging to 
different gene clusters cocirculate, 
some genetically close strains domi-
nated during certain periods, e.g., the 
C025-like strain (6/14) was dominant 
during the study period. A similar dis-
tribution pattern is observed in epi-
demics of HRV-A and HRV-B (9,10).
In conclusion, HRV-C strains 
were detected in hospitalized children 
with lower acute RTIs in Beijing. Co-
infections were common and complex, 
which indicates that the role of HRV-C 
in patients with multiple infections 
should be further investigated. Our 
ﬁ   ndings provide additional evidence 
that HRV-C is spreading globally (8) 
and suggest that HRV-C infections 
should be considered a serious public 
health concern.
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Figure. Phylogenetic analysis of the viruses detected in this study based on the nucleotide 
sequences of the virus capsid protein (VP)4/VP2 region. Using the VP4/VP2 nucleotide 
sequence (258 nt), we performed neighbor-joining analysis by applying the Kimura 
2-parameter model in MEGA software version 4.0 (www.megasoftware.net). Bootstrap 
values from 1,000 replicates are shown next to the branches. The scale bar indicates 
evolutionary distance. Representative viruses from the different human respiratory virus 
(HRV) groups are included. GenBank accession numbers for reference sequences are 
indicated in parentheses.
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Serogroup A 
Neisseria 
meningitidis 
with Reduced 
Susceptibility 
to Ciproﬂ  oxacin
To the Editor: Reduced suscep-
tibility to ciproﬂ  oxacin  of  Neisseria 
meningitidis has been reported with 
increasing frequency since 1992, 
mainly because of mutations in the 
quinolone resistance determining re-
gions (QRDRs) of the gyrase and 
topoisomerase IV genes (1,2). Re-
duced  ﬂ  uoroquinolone  susceptibility 
due to gyrase A mutations in serogroup 
A strains has previously been reported 
from a 2005 outbreak in Delhi, India 
(1). We describe 2 clinical isolates of 
serogroup A N. meningitidis with re-
duced ciproﬂ  oxacin susceptibility that 
were recognized in March 2003 and 
April 2006 in Israel, a country with 
low incidence of invasive meningo-
coccal disease (<2/100,000/laborato-
ry-conﬁ  rmed cases/year) in which this 
serogroup accounts for <2% of cases 
(data from the National Center for 
Meningococci, Tel Hashomer, Israel). 
The 2 isolates in question 
(M12/03 and M24/06; sufﬁ  xes denote 
year of isolation) were compared with 
2 fully susceptible strains, M44/01 
and M23/00 (online Appendix Table, 
available from www.cdc.gov/EID/
content/14/10/1667-appT.htm). MICs 
were measured by Etest (AB Biodisk, 
Solna, Sweden) on Mueller-Hinton 
agar (Difco Laboratories, Detroit, MI, 
USA) supplemented with 5% sheep 
blood. Demographic information was 
obtained from the Israel Ministry of 
Health Department of Epidemiology. 
Chromosomal DNA was isolated 
by using the NucleoBond kit (Mach-
erey-Nagel, Düren, Germany). The 
location of the QRDR in gyrase and 
topoisomerase IV genes was based 
upon prior studies in meningococci 
(online Appendix Table)  and on the 
complete sequence of  strain N. men-
ingitidis Z2491 (serogroup A; Gen-
Bank accession no. NC_003116). We 
ampliﬁ   ed and sequenced extended 
regions encompassing the QRDRs by 
using the upstream and downstream 
primer pairs in gyrA (522 bases) 5′-
GTTCCGCGTCAAAATATGCT-3′, 
5′-CCGAAATTGACGGTTTCTTC-
3′; gyrB (649 bases) 5′-GGTTTGACC
TGCGTGTTGTC-3′, 5′-CGGCTGG
GCGATATAGATG-3′;  parC  (635 
bases) 5′-CACTATGGTTTGCCGT
TTTG-3′, 5′-ATTTCGGACAACAG
CAATTC-3′; and parE (610 bases) 5′-
GGACAGGATGGCGATTTTG-3′, 5′-
CGTCAGCAACTTCATCAACC-3′. 
PCR was performed by using Taq 
DNA polymerase (New England 
BioLabs, Beverly, MA, USA). DNA 
sequencing was performed using the 
ABI PRISM 3700 Genetic Analyzer 
(Applied Biosystems, Foster City, 
CA, USA). Screening for plasmid-
mediated quinolone resistance genes 
was carried out by multiplex PCR am-
pliﬁ  cation of qnrA, qnrB, and qnrS as 
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